Getting to "know" Dew more and more as I read his posts, I would be surprised if he has any "specific" comment at all.
I see more like a "doctor evil" character with his pinky at the corner of his mouth "but what about the new IND isn't that kind of scary????"
"But what about the TRIAL DESIGN?????"
I'd love to be proven wrong and I'm (mostly) teasing Dew but like docbanker says Dew hasn't really had much to say on the topic of Repros that has anything of substance. Where's the beef, Dew?
Seriously, Dew, I would love to hear (or see) your thoughts on why the trial design was an issue.
Market Data 
Markets 
AI
